These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35989450)

  • 1. Coronary microvascular dysfunction is an independent predictor of developing cancer in patients with non-obstructive coronary artery disease.
    Rajai N; Ahmad A; Toya T; Sara JD; Herrmann J; Lerman LO; Lerman A
    Eur J Prev Cardiol; 2023 Feb; 30(3):209-216. PubMed ID: 35989450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease.
    Naya M; Aikawa T; Manabe O; Obara M; Koyanagawa K; Katoh C; Tamaki N
    Heart Vessels; 2021 Jul; 36(7):917-923. PubMed ID: 33484293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of coronary microvascular dysfunction among chest pain patients in the emergency department.
    Safdar B; D'Onofrio G; Dziura J; Russell RR; Johnson C; Sinusas AJ
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):5-13. PubMed ID: 29543037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
    Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
    Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women with coronary microvascular dysfunction and no obstructive coronary artery disease have reduced exercise capacity.
    Bechsgaard DF; Hove JD; Suhrs HE; Bové KB; Shahriari P; Gustafsson I; Prescott E
    Int J Cardiol; 2019 Oct; 293():1-9. PubMed ID: 31345648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sex on coronary microvascular dysfunction and cardiac outcomes.
    Murthy VL; Naya M; Taqueti VR; Foster CR; Gaber M; Hainer J; Dorbala S; Blankstein R; Rimoldi O; Camici PG; Di Carli MF
    Circulation; 2014 Jun; 129(24):2518-27. PubMed ID: 24787469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With Coronary Microvascular Dysfunction Have Less Circulating α-Klotho.
    Akhiyat N; Ozcan I; Gulati R; Prasad A; Tchkonia T; Kirkland JL; Lewis B; Lerman LO; Lerman A
    J Am Heart Assoc; 2024 May; 13(9):e031972. PubMed ID: 38639380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.
    Bajaj NS; Osborne MT; Gupta A; Tavakkoli A; Bravo PE; Vita T; Bibbo CF; Hainer J; Dorbala S; Blankstein R; Bhatt DL; Di Carli MF; Taqueti VR
    J Am Coll Cardiol; 2018 Aug; 72(7):707-717. PubMed ID: 30092946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and Respiratory Diseases in Patients with Coronary Microvascular Dysfunction.
    Freund O; Shetrit A; Bar-Shai A; Zornitzki L; Frydman S; Banai A; Shamir RA; Ben-Shoshan J; Arbel Y; Banai S; Konigstein M
    Am J Med; 2024 Jun; 137(6):538-544.e1. PubMed ID: 38485108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.
    Bechsgaard DF; Hove JD; Michelsen MM; Mygind ND; Pena A; Hansen PR; Hansen HS; Kastrup J; Høst N; Gustafsson I; Prescott E
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):85-94. PubMed ID: 33030280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus and Association With All-Cause Mortality.
    Liao KP; Huang J; He Z; Cremone G; Lam E; Hainer JM; Morgan V; Bibbo C; Di Carli M
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):159-165. PubMed ID: 31705724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Microvascular Indices Reveal Peripheral Vascular Abnormalities in Patients With Suspected Coronary Microvascular Dysfunction.
    Nardone M; Miner S; McCarthy M; Ardern CI; Edgell H
    Can J Cardiol; 2020 Aug; 36(8):1289-1297. PubMed ID: 32553821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ;
    J Am Heart Assoc; 2022 May; 11(9):e025171. PubMed ID: 35475358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of coronary microvascular dysfunction in patients with atrial fibrillation.
    Mohammed AA; Li S; Zhang H; Abdu FA; Mohammed AQ; Zhang W; Al-Hashedi EM; Xu Y; Che W
    Microvasc Res; 2024 Jul; 154():104685. PubMed ID: 38593952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.
    Safdar B; Guo X; Johnson C; D'Onofrio G; Dziura J; Sinusas AJ; Testani J; Rao V; Desir G
    Int J Cardiol; 2019 Mar; 279():155-161. PubMed ID: 30630613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry.
    Boerhout CKM; de Waard GA; Lee JM; Mejia-Renteria H; Lee SH; Jung JH; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Appelman Y; Doh JH; Christiansen EH; Banerjee R; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Beijk MAM; Knaapen P; Escaned J; Kakuta T; Koo BK; Piek JJ; van de Hoef TP
    EuroIntervention; 2022 Oct; 18(9):719-728. PubMed ID: 35694826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
    Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
    Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.
    Pena A; Michelsen MM; Mygind ND; Gustafsson I; Høst N; Bech J; Kastrup J; Hansen HS; Hansen PR; Prescott E
    Echocardiography; 2019 Jun; 36(6):1110-1117. PubMed ID: 31012159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Schroder J; Michelsen MM; Mygind ND; Suhrs HE; Bove KB; Bechsgaard DF; Aziz A; Gustafsson I; Kastrup J; Prescott E
    Eur Heart J; 2021 Jan; 42(3):228-239. PubMed ID: 33477168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.